Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors

Hamberg, 1975, Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides, Proc Natl Acad Sci USA, 72, 2994, 10.1073/pnas.72.8.2994 Moncada, 1978, Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin, Pharmacol Rev, 30, 293 Wenzel, 1997, Arachidonic acid metabolites: mediators of inflammation in asthma, Pharmacotherapy, 17, 3S Patrono, 1998, Prevention of myocardial infarction and stroke by aspirin: different mechanisms? Different dosage?, Thromb Res, 92, S7, 10.1016/S0049-3848(98)00101-7 Dogné, 2002, Therapeutic potential of thromboxane inhibitors in asthma, Expert Opin Invest Drugs, 11, 275, 10.1517/13543784.11.2.275 Sladek, 1990, Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin, Am Rev Respir Dis, 141, 1441, 10.1164/ajrccm/141.6.1441 Gurbel, 1999, Plasma thromboxane and prostacyclin are linear related and increased in patients presenting with acute myocardial infarction, Prostaglandins Leukot Essent Fatty Acids, 61, 7, 10.1054/plef.1999.0064 Wilson, 2000, Ridogrel: an antiplatelet agent with antihypertensive properties, Cardiovasc Drug Rev, 18, 222, 10.1111/j.1527-3466.2000.tb00045.x Galie, 2002, The new clinical trials on pharmacological treatment in pulmonary arterial hypertension, Eur Respir J, 20, 1037, 10.1183/09031936.02.05542002 Savage, 1995, Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-hospital eastern Atlantic restenosis trial (M-HEART II), Circulation, 92, 3194, 10.1161/01.CIR.92.11.3194 Hoshino, 1999, Effect of AA-2414, a thromboxane A2 recepteur antagonist, on airway inflammation in subjects with asthma, J Allergy Clin Immunol, 103, 1054, 10.1016/S0091-6749(99)70179-X Friedel, 1991, Torasemide. A review of its pharmacological properties and therapeutic potential, Drugs, 41, 81, 10.2165/00003495-199141010-00008 Uchida, 1992, A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in the isolated canine coronary artery, Prostaglandins Leukot Essent Fatty Acids, 45, 121, 10.1016/0952-3278(92)90227-A Dogne, 2001, Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531, Cardiovasc Drug Rev, 19, 87, 10.1111/j.1527-3466.2001.tb00057.x Dogné, 2001, Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor, J Pharm Pharmacol, 53, 669, 10.1211/0022357011775992 Dogne, 2003, Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function, Prostaglandins Leukot Essent Fatty Acids, 68, 49, 10.1016/S0952-3278(02)00236-3 Rolin, 2001, Activity of a novel dual thromboxane A(2) receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles, Prostaglandins Leukot Essent Fatty Acids, 65, 67, 10.1054/plef.2001.0290 Rolin, 2003, BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis, J Pharmacol Exp Ther, 306, 59, 10.1124/jpet.102.046607 Dogne, 2004, Pharmacological characterization of BM-573, a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time, J Pharmacol Exp Ther, 309, 498, 10.1124/jpet.103.063610 Masereel, 1994, Synthesis and pharmacology of pyrid-3-yl sulfonylureas and sulfonylthioureas as inhibitors of the astrocytic Na+2Cl−K+ co-transporter, Eur J Med Chem, 29, 527, 10.1016/0223-5234(94)90145-7 Nuhrich, 1996, Use of infrared spectroscopy in monitoring of a new method for the preparation of sulotroban, an antithrombotic drug, J Chem Educ, 319, 689 Masereel, 1999, Thromboxane A2 receptor antagonism in man and rat by a sulphonylcyanoguanidine (BM-144) and a sulphonylurea (BM-500), J Pharm Pharmacol, 51, 695, 10.1211/0022357991772998 Dogné, 2000, Effects of a novel non carboxylic thromboxane A2 receptor antagonist (BM-531) derived from torasemide on platelet function, Prostaglandins Leukot Essent Fatty Acids, 52, 311, 10.1054/plef.2000.0160 Born, 1963, The aggregation of blood platelets, J Physiol, 168, 178, 10.1113/jphysiol.1963.sp007185 Harris, 1979, Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives, J Cyclic Nucleotide Res, 5, 125 Pradelles, 1985, Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay, Anal Chem, 57, 1170, 10.1021/ac00284a003 Johnson, 1986, Thromboxane A2 synthase inhibitors. 5-(3-Pyridylmethyl)benzofuran-2-carboxylic acids, J Med Chem, 29, 1461, 10.1021/jm00158a024 Mohrland, 1989, Thromboxane synthase activity and platelet function after furegrelate administration in man, J Clin Pharmacol, 29, 53, 10.1002/j.1552-4604.1989.tb03237.x de Leval, 2001, Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood, Prostaglandins Leukot Essent Fatty Acids, 64, 211, 10.1054/plef.2001.0262 Michaux, 2001, Structure determination and comparison of BM567, a sulfonylurea, with terbogrel, two compounds with dual action, thromboxane receptor antagonism and thromboxane synthase inhibition, Bioorg Med Chem Lett, 11, 1019, 10.1016/S0960-894X(01)00114-7 Yamamoto, 1993, Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction, J Med Chem, 36, 820, 10.1021/jm00059a005 Balant, 1981, Clinical pharmacokinetics of sulfonylurea hypoglycemic drugs, Clin Pharmacokinet, 6, 215, 10.2165/00003088-198106030-00003 Moore, 2002, Thromboxane receptor signalling in human myometrial cells, Prostaglandins Other Lipid Mediat, 67, 31, 10.1016/S0090-6980(01)00169-1 Ogletree, 1992, Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles, J Pharmacol Exp Ther, 260, 789 Zhang, 1996, Characterization of thromboxane A2/prostaglandin endoperoxide receptors in aorta, Eur J Pharmacol, 317, 91, 10.1016/S0014-2999(96)00697-8 Kemp, 1998, Interspecies differences in thromboxane A2 receptors are distinguished by glibenclamide, Eur J Pharmacol, 354, 173, 10.1016/S0014-2999(98)00450-6